Complementary and alternative medicine (CAM) information and support needs of Chinese-speaking cancer patients
Complementary and alternative medicine (CAM) is popular among Chinese-speaking cancer patients (CSCPs), but little research examines CAM use by Canadian CSCPs. The use of CAM is controversial because of potential interactions with conventional cancer treatments. The purpose of this study was to explore CSCPs’ use of CAM, sources of CAM information, and decision support needs, as well as their experience of making CAM decisions.
A sequential, multi-method research design was used: a secondary data analysis of a CAM use survey conducted in a Western Canadian regional cancer agency followed by a qualitative interpretive description approach to inquiry using semi-structured interviews with CSPCs and support persons.
More than 65% of CSCPs reported using CAM. CSCPs favored biologically-based therapies, including traditional Chinese medicine herbs and other natural health products. Many CSCPs were using CAM without adequate culturally appropriate information and decision support. Those who made decisions spontaneously relied on peers for advice whereas deliberate decision makers sought information from multiple sources, including peers and the Internet, selecting therapies congruent with their cultural health perspectives and previous experiences with CAM. CSCPs rarely spoke with oncology healthcare providers (HCPs) about CAM use.
CSCPs reported using CAM at rates significantly higher than for non-CSCPs. Given the predominance of biological-based therapies and the lack of consultation with oncology HCPs, it is imperative that CAM use be assessed and documented to ensure CSCPs’ safety during cancer treatment. Culturally appropriate information and decision support is required to ensure that CSCPs are making safe and informed CAM decisions.
KeywordsComplementary therapies Chinese-Canadian Cancer Qualitative research Immigrants
Complementary and alternative medicine
Complementary Medicine Education and Outcomes research program
Chinese-speaking cancer patient
Natural health product
Traditional Chinese medicine
Compliance with ethical standards
Conflict of interest
The CAMEO research program was funded by an unrestricted research grant from the Lotte and John Hecht Memorial Foundation (2007–2014). The authors have no financial relationship with this organization and had full control of all primary data that informed this manuscript. The primary data is available to the editors of the Journal of Supportive Care in Cancer, upon request.
- 6.King N, Balneaves LG, Levin GT, Nguyen T, Nation JG, Card C, Truant TLO, Carlson LE (2015) Surveys of cancer patients and cancer health care providers regarding complementary therapy use, communication, and information needs. Integr Cancer Ther 14(6):515–524. https://doi.org/10.1177/1534735415589984 CrossRefPubMedGoogle Scholar
- 7.Evans M, Shaw A, Thompson EA, Falk S, Turton P, Thompson T, Sharp D (2007) Decisions to use complementary and alternative medicine (CAM) by male cancer patients: information-seeking roles and types of evidence used. BMC Complement Altern Med 7(25):25. https://doi.org/10.1186/1472-6882-7-25 CrossRefPubMedPubMedCentralGoogle Scholar
- 9.White M, Verhoef M (2006) Cancer as part of the journey: the role of spirituality in the decision to decline conventional prostate cancer treatment and to use complementary and alternative medicine. Integr Cancer Ther 5(2):117–112. https://doi.org/10.1177/1534735406288084 CrossRefPubMedGoogle Scholar
- 11.Kakai H, Maskarinec G, Shumay DM, Tatsumura Y, Katsuya T (2003) Ethnic differences in choices of health information by cancer patients using complementary and alternative medicine: an exploratory study with correspondence analysis. Soc Sci Med 56(4):851–862. https://doi.org/10.1016/S0277-9536(02)00086-2 CrossRefPubMedGoogle Scholar
- 13.Statistics Canada (2011) Immigration and ethnocultural diversity in Canada. Statistics Canada catalogue no. 99-010-X2011001. Ottawa. http://www12.statcan.gc.ca/nhs-enm/2011/as-sa/99-010-x/99-010-x2011001-eng.pdf. Accessed 9 Aug 2017
- 15.Teng L, Jin K, He K, Bian C, Chen W, Fu K, Zhu T, Jin Z (2010) Use of complementary and alternative medicine by cancer patients at Zhejiang University Teaching Hospital, Zhuji Hospital, China. Afr J Tradit Complement Altern Med 7(4):322–330. https://doi.org/10.4314/ajtcam.v7i4.56699 CrossRefPubMedPubMedCentralGoogle Scholar
- 19.Balneaves LG, Truant TLO, Verhoef MJ, Ross B, Porcino AJ, Wong ME, Brazier AS (2012) The Complementary Medicine Education and Outcomes (CAMEO) program: a foundation for patient and health professional education and decision support programs. Patient Educ Couns 89(3):461–466. https://doi.org/10.1016/j.pec.2012.01.005 CrossRefPubMedGoogle Scholar
- 20.SPSS (2006) SPSS statistics. Version 15.0. SPSS, ChicagoGoogle Scholar
- 23.Brown C, Barner J, Bohman T, Richards K (2009) A multivariate test of an expanded Andersen Health Care utilization model for complementary and alternative medicine (CAM) use in African Americans. J Altern Complement Med 15(8):911–919. https://doi.org/10.1089/acm.2008.0561 CrossRefPubMedPubMedCentralGoogle Scholar
- 24.Thorne S (2016) Interpretive description: qualitative research for applied practice. Routledge, New YorkGoogle Scholar
- 29.NVivo (2008) NVivo qualitative data analysis software, version 8. QSR International Pty Ltd, DoncasterGoogle Scholar
- 30.Schofield P, Diggens J, Charleson C, Marigliani R, Jefford M (2010) Effectively discussing complementary and alternative medicine in a conventional oncology setting: communication recommendations for clinicians. Patient Educ Couns 79(2):143–115. https://doi.org/10.1016/j.pec.2009.07.038 CrossRefPubMedGoogle Scholar
- 32.Zeller T, Muenstedt K, Stoll C, Schweder J, Senf B, Ruckhaeberle E, Becker S, Serve H, Huebner J (2013) Potential interactions of complementary and alternative medicine with cancer therapy in outpatients with gynecological cancer in a comprehensive cancer center. J Cancer Res Clin Oncol 139(3):357–365. https://doi.org/10.1007/s00432-012-1336-6 CrossRefPubMedGoogle Scholar
- 34.Deng GE, Frenkel M, Cohen L, Cassileth BR, Abrams DI, Capodice JL, Courneya KS, Dryden T, Hanser S, Kumar N, Labriola D, Wardell DW, Sagar S (2009) Evidence-based clinical practice guidelines for integrative oncology: complementary therapies and botanicals. J Soc Integr Oncol 7(3):83–84. https://doi.org/10.2310/7200.2009.0019 CrossRefGoogle Scholar
- 35.Greenlee H, Balneaves L, Carlson LE, Cohen M, Deng G, Hershman D, Mumber M, Perlmutter J, Seely D, Sen A, Zick SM, Tripathy D (2014) Clinical practice guidelines on the use of integrative therapies as supportive care in patients treated for breast cancer. J Natl Cancer Inst Monogr 2014(50):346–358. https://doi.org/10.1093/jncimonographs/lgu041 CrossRefPubMedPubMedCentralGoogle Scholar